Five things for pharma marketers to know: Thursday, November 16, 2017
Docs biased against research from poor countries, study finds; Astellas probed over patient-assistance charity support; Acorda reports deaths in Parkinson’s trial
Docs biased against research from poor countries, study finds; Astellas probed over patient-assistance charity support; Acorda reports deaths in Parkinson’s trial
Drugmakers can do a better job of organizing dosing information, safety information, and clinical data on their brand websites, a new survey found.
Drugmakers routinely pay ghostwriters to write industry-funded research articles; Horizon to buy Raptor for $800 million; WellDoc partners with J&J
Here are the brands and companies that advertised the most on professional ads in 2015.
Following print’s best year since 2011, it’s time to rewrite those journal-advertising obituaries. Medical-surgical print journal spending in 2015 was up 8.4% to $372 million.
New analysis says Paxil is not safe or effective for teens; some FDA reviewers voted against Addyi approval over side effects; HHS partners with AstraZeneca on antibiotic development
Elsevier is taking a hard-line posture against several different universities, asking them to take down scholarly research.
The Heath, Labor and Welfare ministry says a publisher passed off advertorials as articles.
Doctors shared their information preferences with CMI/Compas, revealing ways marketers can better pace their communications to max out channels.